Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Cordycepin Plus Pentostatin in Patients With Refractory TdT-Positive Leukemia

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified January 2009 by OncoVista, Inc..
Recruitment status was:  Recruiting
Sponsor:
Collaborator:
AAIPharma
Information provided by:
OncoVista, Inc.
ClinicalTrials.gov Identifier:
NCT00709215
First received: June 30, 2008
Last updated: January 8, 2009
Last verified: January 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2010
  Estimated Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)